Related Experiment Video

Updated: Nov 1, 2025

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.2K

Palmoplantar pompholyx secondary to interleukin 17A inhibitor therapy for psoriasis: A case series

Melissa Peera1,2, Annika Smith1,2

  • 1Department of Dermatology, Westmead Hospital, Sydney, New South Wales, Australia.

JAAD Case Reports
|June 18, 2021
PubMed
Abstract

No abstract available in PubMed .

Keywords:
IL-17 inhibitorIL-17, interleukin-17Th, t helperadverse reactionanti-IL-17biologicdrug reactiondyshidrotic eczemaeczemainterleukin-17 inhibitorpalmoplantar pompholyxpsoriasissecukinumab

More Related Videos

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

577
Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture10:31

Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture

Published on: April 8, 2016

14.9K

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.6K